Compare Rajnish Wellness with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 6.06% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.14
Flat results in Dec 25
Risky - Negative EBITDA
Stock DNA
Pharmaceuticals & Biotechnology
INR 47 Cr (Micro Cap)
NA (Loss Making)
49
0.00%
-0.01
-1.00%
0.44
Total Returns (Price + Dividend) 
Rajnish Wellness for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 May 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Rajnish Wellness Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
Rajnish Wellness Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 13 April 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weak valuation metrics, signalling heightened risk for investors amid ongoing operational challenges.
Read full news article Announcements 
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
21-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Rajnish Wellness Ltd |
| 2 | CIN NO. | L52100MH2015PLC265526 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.17 |
| 4 | Highest Credit Rating during the previous FY | 0 |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
Designation: Company Secretary
EmailId: cs@rajnishwellness.com
Designation: Chief Financial Officer
EmailId: mihirpatwa7@gmail.com
Date: 21/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSECompliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
25-Mar-2026 | Source : BSEintimation of closure of trading window
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23
Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22
Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.43%)
Rajnish Kumar Singh (9.16%)
Jasmit Singh Chandhok (1.92%)
86.0%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 93.67% vs 163.16% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -1,616.67% vs -72.73% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024
Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -6.97% vs -12.05% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -223.53% vs -32.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -36.67% vs 206.35% in Mar 2024
YoY Growth in year ended Mar 2025 is -83.50% vs 123.91% in Mar 2024






